Lombard Odier Asset Management (Switzerland)’s Medifast MED Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-75,000	Closed	-$7.78M	–	289
2023 Q1	$7.78M	Sell	75,000 -75,400	-50%	-$8.36M	0.68%	41
2022 Q4	$17.3M	Buy	150,400 +400	+0.3%	+$46.6K	1.39%	23
2022 Q3	$16.3M	Hold	150,000	–	–	1.38%	27
2022 Q2	$27.1M	Sell	150,000 -25,000	-14%	-$4.47M	2.29%	4
2022 Q1	$29.9M	Hold	175,000	–	–	2.34%	7
2021 Q4	$36.6M	Buy	175,000 +55,000	+46%	+$11.4M	2.34%	6
2021 Q3	$23.1M	Buy	120,000 +35,000	+41%	+$8.6M	1.44%	31
2021 Q2	$24.1M	Buy	85,000 +5,000	+6%	+$1.35M	1.22%	30
2021 Q1	$16.9M	Sell	80,000 -30,000	-27%	-$7.18M	1.12%	32
2020 Q4	$21.6M	Buy	110,000 +55,000	+100%	+$9.72M	2.44%	13
2020 Q3	$9.04M	Buy	+55,000	New	+$9.06M	0.95%	38

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s MED Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Medifast (MED) in Q2 2023, closing a stake of 75,000 shares — an estimated $7.78M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in MED in Q3 2020 and held it in 11 quarters. The position peaked at $36.6M in Q4 2021. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Lombard Odier Asset Management (Switzerland) reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 75,000 Medifast shares in Q2 2023, an estimated $7.78M.
Lombard Odier Asset Management (Switzerland) first reported a position in Medifast in Q3 2020 and held it in 11 quarters.
Lombard Odier Asset Management (Switzerland)'s Medifast position peaked at $36.6M in Q4 2021.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.